Published in PLoS One on March 24, 2014
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol (2000) 128.08
Global functional profiling of gene expression. Genomics (2003) 12.05
Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate. Nucleic Acids Res (2003) 9.30
Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction. Science (2000) 7.86
MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci (2004) 5.95
Multiple receptors for dopamine. Nature (1979) 5.51
Dichotomous dopaminergic control of striatal synaptic plasticity. Science (2008) 5.47
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature (2007) 4.36
Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation. Science (1997) 4.25
Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci U S A (2004) 3.87
Effects of filtering by Present call on analysis of microarray experiments. BMC Bioinformatics (2006) 3.86
DARPP-32: an integrator of neurotransmission. Annu Rev Pharmacol Toxicol (2004) 3.84
Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat Neurosci (2002) 3.34
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat Neurosci (2003) 3.25
Slowed recovery of rod photoresponse in mice lacking the GTPase accelerating protein RGS9-1. Nature (2000) 3.11
Regulation of Ca2+-permeable AMPA receptors: synaptic plasticity and beyond. Curr Opin Neurobiol (2006) 3.10
Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J Neurosci (1996) 2.89
Computation with the KEGG pathway database. Biosystems (1998) 2.79
Rapid synthesis and synaptic insertion of GluR2 for mGluR-LTD in the ventral tegmental area. Science (2007) 2.77
DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature (1984) 2.74
RGS9 modulates dopamine signaling in the basal ganglia. Neuron (2003) 2.61
DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J Neurosci (1984) 2.39
Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. J Neurosci (2005) 2.18
Pleckstrin's repeat performance: a novel domain in G-protein signaling? Trends Biochem Sci (1996) 2.13
D2 dopamine receptors in striatal medium spiny neurons reduce L-type Ca2+ currents and excitability via a novel PLC[beta]1-IP3-calcineurin-signaling cascade. J Neurosci (2000) 2.13
Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia. J Neurosci (2007) 2.11
Cross-modal regulation of synaptic AMPA receptors in primary sensory cortices by visual experience. Nat Neurosci (2006) 1.98
Psychosis pathways converge via D2high dopamine receptors. Synapse (2006) 1.78
Comparing the use of Affymetrix to spotted oligonucleotide microarrays using two retinal pigment epithelium cell lines. Mol Vis (2003) 1.77
D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways. J Neurosci (2005) 1.74
Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies. Neurosignals (2008) 1.73
Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors. Biol Psychiatry (2007) 1.65
A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function. Neurobiol Dis (2004) 1.65
Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen. Brain Res (1998) 1.54
Mammalian RGS proteins: multifunctional regulators of cellular signalling. Semin Cell Dev Biol (2006) 1.54
L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice. J Neurochem (2009) 1.53
Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation. Biol Psychiatry (2009) 1.44
RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease. J Neurosci (2007) 1.35
D2 dopamine receptors reduce N-type Ca2+ currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein-kinase-C-insensitive pathway. J Neurophysiol (1997) 1.33
The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia. J Biol Chem (2010) 1.33
Distinct patterns of bidirectional regulation of mammalian adenylyl cyclases. J Biol Chem (1994) 1.29
RGS9-2 modulates D2 dopamine receptor-mediated Ca2+ channel inhibition in rat striatal cholinergic interneurons. Proc Natl Acad Sci U S A (2004) 1.26
Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease. Sci Transl Med (2010) 1.23
Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses. J Neurophysiol (2001) 1.21
A randomized controlled trial comparing pramipexole with levodopa in early Parkinson's disease: design and methods of the CALM-PD Study. Parkinson Study Group. Clin Neuropharmacol (2000) 1.13
Motor coordination deficits in mice lacking RGS9. Brain Res (2007) 1.11
RGS9: a regulator of G-protein signalling with specific expression in rat and mouse striatum. J Neurosci Res (1998) 1.09
Regulators of G protein signaling: a bestiary of modular protein binding domains. J Neurochem (2000) 1.09
Late-onset motoneuron disease caused by a functionally modified AMPA receptor subunit. Proc Natl Acad Sci U S A (2005) 1.06
Gα(olf) mutation allows parsing the role of cAMP-dependent and extracellular signal-regulated kinase-dependent signaling in L-3,4-dihydroxyphenylalanine-induced dyskinesia. J Neurosci (2012) 1.01
Dopamine-modulated potassium channels on rat striatal neurons: specific activation and cellular expression. J Neurosci (1995) 1.01
[11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors. Neurology (1994) 0.97
Physiological and molecular properties of AMPA/Kainate receptors expressed by striatal medium spiny neurons. Dev Neurosci (1998) 0.95
The complex of G protein regulator RGS9-2 and Gβ(5) controls sensitization and signaling kinetics of type 5 adenylyl cyclase in the striatum. Sci Signal (2012) 0.95
Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and in postmortem schizophrenia brain. Synapse (2007) 0.95
Long-term depression requires postsynaptic AMPA GluR2 receptor in adult mouse cingulate cortex. J Cell Physiol (2007) 0.93
Physiology of basal ganglia disorders: an overview. Can J Neurol Sci (1993) 0.93
Dopamine D1-D2 receptor heteromer in dual phenotype GABA/glutamate-coexpressing striatal medium spiny neurons: regulation of BDNF, GAD67 and VGLUT1/2. PLoS One (2012) 0.92
V2 vasopressin receptor deficiency causes changes in expression and function of renal and hypothalamic components involved in electrolyte and water homeostasis. Am J Physiol Renal Physiol (2008) 0.91
Comparison of microarray and quantitative real-time PCR methods for measuring MicroRNA levels in MSC cultures. Methods Mol Biol (2011) 0.85
Expression of a dopamine D2 receptor-activated K+ channel on identified striatopallidal and striatonigral neurons. Proc Natl Acad Sci U S A (1998) 0.83
Dyskinesia: L-dopa-induced and tardive dyskinesia. Clin Neuropharmacol (2002) 0.83
Deletion of Go2alpha abolishes cocaine-induced behavioral sensitization by disturbing the striatal dopamine system. FASEB J (2008) 0.81
Quinolinate-induced rat striatal excitotoxicity impairs endoplasmic reticulum Ca2+-ATPase function. Neurochem Res (2008) 0.78
Modulation of adenylyl cyclase activity in rat striatal homogenate by dopaminergic receptors. J Pharmacol Sci (2008) 0.78
How to wake a giant. Oncotarget (2015) 0.76